Abstract
The emerging consensus regarding transdiagnostic and dimensional models of psychopathology has important implications for the development of effective approaches for early intervention and prevention of psychiatric conditions. Consistent with biological, epidemiological and clinical evidence, transdiagnostic prevention focuses on reducing risk factors and/or preventing outcomes that are shared across populations who may be at risk for a range of psychiatric disorders. This narrative review describes some of the efforts made to date to develop and test interventions aiming to support universal, selective, and indicated prevention of psychiatric conditions in a transdiagnostic manner, during childhood, adolescence, and early adulthood. An evidence-based transdiagnostic approach to the prevention of mental illness in youth, that accounts for the existing body of knowledge about transdiagnostic risk factors as well as constraints impacting “real world” feasibility of these approaches, has the broad potential to ultimately reduce the incidence and severity of psychiatric illnesses.
Similar content being viewed by others
Introduction: transdiagnostic prevention in psychiatry
The need for prevention-focused mental health programs for youth is becoming more urgent, as a global youth mental health crisis [1] and the related workforce shortage in mental health care [2, 3] continue to worsen. A widespread implementation of successful preventive interventions that decreases the incidence or severity of mental illnesses would have far-reaching benefits in terms of reducing suffering, disability and the economic consequences of these often lifelong conditions, which typically begin during the first few decades of life.
Much of the prior research on primary prevention in mental health has focused on preventing the onset of specific Diagnostic and Statistical Manual of mental disorders (DSM)-defined disorders or related outcomes. For instance, there have been many randomized control trials (RCTs) examining the efficacy of interventions for preventing major depression [4], anxiety disorders [5], eating disorders [6], postpartum depression [7, 8], substance use disorders [9], and psychotic disorders [10]. However, a prevention approach in psychiatry that is, to a varying extent, transdiagnostic (aiming to prevent more than one disorder) has also gained traction in recent years [11], particularly as evidence for the potential cost-effectiveness of this strategy has accumulated [12,13,14].
Historically, at first, transdiagnostic treatments of existing psychiatric disorders were developed, emerging from a recognition of the extensive comorbidity and symptom overlap of psychiatric conditions, particularly across internalizing (e.g., mood and anxiety) disorders, leading to the development of transdiagnostic psychotherapy approaches for treating these conditions [15]. More recently, prevention frameworks in psychiatry have also become increasingly transdiagnostic, with the ultimate goal of reducing the onset of multiple, potentially mechanistically-related, psychiatric illnesses in individuals with transdiagnostic risk factors [16, 17]. Empirically, the evidence for shared genetic and environmental risk factors and overlapping neurobiological and psychological manifestations of psychiatric illnesses (see companion paper to this article, Part 1 [18]) may ultimately lead to further refinement of transdiagnostic preventive approaches, with the development of interventions that target such shared risk factors. In this narrative review, we describe approaches to transdiagnostic prevention in psychiatry that have been developed and tested to date, highlighting key examples with discussion of their strengths and limitations, and suggestions for future directions for the field.
A wide range of therapeutic approaches have been employed in transdiagnostic prevention programs, including behavioral interventions, psychotropic medications, neuromodulation, neurofeedback, and supplements [19,20,21]. Given that behavioral approaches have undergone the largest amount of testing and typically have favorable risk-benefit ratios – an important feature of a prevention program for populations with low to moderate levels of risk—we have limited the focus of this article to behavioral interventions used for transdiagnostic prevention of mental illnesses in youth.
Preventive interventions, including transdiagnostic ones, can be provided to an entire population regardless of risk level (universal prevention), to individuals with one or more relatively “silent” risk factors such as a family history of a disorder, or a history of early adversity (selective prevention), or to those with subclinical symptoms of illness (indicated) [22]. Each of these three types of approaches can play a role in a tiered or stage-based approach to the prevention of mental illnesses [17, 23]. Below, we describe examples of each of these strategies as applied to a transdiagnostically at-risk population and/or to prevent transdiagnostic outcomes. Given evidence that the majority of psychiatric illnesses begin early, during the first two decades of life [24], prevention-focused interventions in psychiatry are often designed for pre-adolescent children (and/or their caregivers), adolescents, or young adults. Because the field of transdiagnostic prevention in psychiatry is still at a relatively early stage, we have mainly described published RCTs, plus a few illustrative, single-arm studies of emerging, novel approaches.
Universal prevention
Overview
Universal prevention programs, which, by definition, target heterogeneous, transdiagnostically at-risk general population samples, including individuals with minimal levels of risk, are typically aimed at improving the psychological well-being of an entire group of individuals within a particular community setting, regardless of risk level. These types of programs include social-emotional or anti-bullying curricula in schools, wellness programs in workplaces, public health awareness campaigns providing information about the early signs of addiction, depression, anxiety, or suicidality, and screenings in pediatric and primary care practices for maltreatment or depression [25]. Such programs have the potential to impact population levels of psychiatric disorders if implemented widely, akin to the impact on general health of taxes on soda and alcohol, public information campaigns about the benefits of good nutrition and exercise or the health risks associated with smoking, and hypertension and cancer screening. The potentially powerful effect of such universally-delivered interventions can be attributed in part to the counter-intuitive “prevention paradox”—that the majority of cases of a disease arise from individuals at moderate or low risk, with only a minority of cases arising from individuals at high risk [26]. Thus, an intervention that reduces a highly prevalent risk factor, even one associated with a small degree of risk, can have a large impact on disease incidence. However, the effectiveness of universal interventions may be limited by the large samples typically needed to observe benefits [16]. Conversely, a universal preventive intervention that reduces the risk for and, ultimately, the incidence of, a number of disorders (i.e., with a transdiagnostic impact) could overcome this limitation [11], particularly since, in aggregate, mental illnesses occur in a large portion ( > 25%) of the population [27, 28].
School-based universal prevention
Universal prevention programs have often been deployed and tested in K-12 schools and colleges, since these are convenient and feasible settings to deliver mental health-focused material to a large number of young people. Also the inclusion of all youth in a particular setting, such as a class or afterschool program, has the benefit of avoiding the potentially stigmatizing effect of selecting youth with certain risk factors or symptom profiles for a mental health intervention. Many of these programs have focused on reducing or preventing common symptoms (rather than disorders), such as anxiety [29], depression [4], suicidality [30], and stress [31].
In addition, some of these programs have focused on a particular behavior that is indirectly linked to mental health, and this may be a particularly effective strategy in youth. For example, one meta-analysis examining the effects of 69 school-based anti-bullying interventions [32] found that they significantly decreased rates of bullying and levels of anxiety and depression. Such “indirect” approaches [33], that focus on addressing specific behaviors or problems that are of concern for youth (e.g., insomnia, overall stress, test anxiety, procrastination, conflicts with peers and other relationship issues, social media use), which are often accompanied by symptoms of depression or anxiety, may be appealing to adolescents and young adults, particularly in light of the minimal stigma associated with many of these topics.
In any school-based programs, teachers are trained to deliver the intervention [34]. One well-studied program that has used this approach is a universal prevention program called the Good Behavior Game (GBG), which has been mainly deployed in young children [35, 36]. GBG focuses on classroom management techniques that employ rules and rewards, aiming to promote positive student behavior [37]. The research on this program has shown that GBG is effective in reducing, as well as preventing (during middle school and early adulthood), aggressive behavior and related outcomes [38, 39]. For example, one study which followed 1,197 first and second grade students who had been randomized to either GBG, a reading curriculum, or standard programming [39], found that, compared to the students assigned to the other conditions, those who had received GBG had lower rates of aggressive behavior, substance use, and anti-social behavior 14 years later.
Mindfulness-based universal preventive interventions have also been studied extensively within schools. One systematic review and meta-analysis of 61 studies of group-based mindfulness interventions conducted across the world (including a total of 6207 students) found evidence for small but significant beneficial effects of these programs on cognitive and socio-emotional outcomes [40]. However, one of the largest RCTs of a mindfulness intervention delivered by teachers (with 8376 adolescents; mean age: 12 years) failed to show mental health benefits of the intervention. This study (the MYRIAD trial) tested an intervention with 10 structured sessions, comprised of psychoeducation, discussion, and brief mindfulness exercises, that were delivered during one semester of school, and compared this intervention to a usual social emotional learning curriculum, with randomization occuring at the school level [41]. While this program showed promise in terms of the feasibility of implementing a structured mindfulness-based intervention within schools, there was no evidence for beneficial effects of the intervention on symptoms of depression, social-emotional behavioral functioning, and wellbeing at the one-year follow-up time point [42]. The trial’s investigators offered several possible explanations for these negative results, such as that the dose of mindfulness training may have been too small; the usual social emotion learning curriculum (the control condition) was beneficial; some students benefited from the active intervention while others did not need it or even experienced worsening when trained to attend to their thoughts and feelings, as observed in other trials [43]; and the meta-cognitive capacities needed to successfully use mindfulness techniques may not be fully developed during early adolescence [42]. Perhaps most importantly, the low acceptability ratings and low engagement levels with the home practice component of the mindfulness intervention highlight the importance of collaboration (co-design) with the targeted youth population when developing preventive behavioral interventions.
Another example of a school-based universal prevention program is the Climate Schools Combined (CSC) intervention, a combination of a substance use and a mental health intervention. CSC aims to concurrently prevent substance abuse, anxiety, and depression via 18 sessions (each comprised of 20 minutes of an individual, online cartoon-based activity, plus 20 minutes of a teacher-led interactive classroom activity) focused on psychoeducation and cognitive behavioral skills [44, 45]. When tested in a cluster-randomized school-based trial that enrolled 6386 adolescents (mean age: 13.5 years), a significantly reduced likelihood of drinking and of experiencing increased anxiety and depression, relative to the mental health-focused control condition, was observed up to 2.5 years after the trial [44]. However, no differences between groups was observed 5 and 6 years later, suggesting that these benefits were temporary [45]. Also, the mental health component alone showed no benefits when compared to a usual health education class [46].
Schools versus other settings
School-based interventions offer many appealing features and potential solutions to the current gaps in mental health care for youth, such as scalability and access to the children who may benefit. Given that children typically spend most of their time in school, it is unsurprising that youth obtain mental health services within schools at a rate equal to or higher than in clinical settings [47]. However, schools often lack the staffing and other resources needed to deliver mental health-related interventions [48]. Also, there is some evidence that school-based programs delivered by non-school staff with some mental health care training (e.g., clinicians, researchers, or graduate students) are more effective, in terms of leading to reductions in anxiety and depression, than those delivered by teachers or other school staff [49, 50]. These findings may be related to some reluctance of students to share their mental health-related experiences with their own teachers.
Delivering universal mental health-promoting interventions in a range of community settings, such as libraries, youth centers, primary care clinics, sports programs, or online, in parallel with school-based programs, may be an effective approach for providing preventive interventions in settings where youth spend their unscheduled (non-school) time. The value of this pathway is supported by the success of community-based youth programs established outside of schools that focus on both promoting mental health and addressing other needs of youth (see below).
Future directions
Strengths and limitations of universal prevention approaches in mental health, including questions about their overall effectiveness, have been extensively discussed and debated recently [51,52,53,54]. One commonly cited limitation is that the training, oversight, and resources dedicated to these programs can be highly variable. Another challenge is that some of the youth receiving these interventions may not need them or show low engagement [55], leading to a variable, often limited impact. These issues may account, in part, for why several prior reviews have described mixed results for these programs, i.e., that they generally have small effects [49, 56] and often lack rigor [49, 57,58,59,60]. Also, some studies have found that, while some of these interventions may show efficacy in reducing or preventing symptoms of depression [58, 61], there is little evidence that they prevent more serious and chronic mental illnesses, such as bipolar disorder or psychosis [58]. Moreover, one meta-analysis found evidence that universal prevention programs are less effective than more targeted prevention programs [62]. Taken together, studies conducted to date suggest that additional, rigorously controlled studies, accompanied by comprehensive training of facilitators and fidelity monitoring, are needed to determine whether some universal prevention interventions are beneficial and cost-effective. One potential strategy that could be tested further in future studies is to make universal programs voluntary [63], which could increase the likelihood that youth with the most interest or need for these programs receive them. Given the nonstigmatizing, accessible features of these programs, and promising findings for some universal interventions in low and middle income countries [50, 54, 64], efforts to develop highly “youth-friendly” universal prevention programs, perhaps with a greater focus on “indirect” behavioral goals rather than explicit mental health ones, are likely worthwhile. Ultimately, universal and targeted prevention programs (see below) may each contribute in complementary ways to a comprehensive, tiered mental health care program for youth [58, 65].
Selective prevention
Overview
Selective prevention strategies focus on individuals with “silent” (asymptomatic) risk factors for illness, such as genetic/familial risk or environmental (e.g., childhood adversity) risk factors, which tend to be transdiagnostic, i.e., they are not specifically linked to elevated risk for developing one psychiatric illness [18]. Selective prevention strategies have not been used frequently in psychiatry, given that these types of risk factors are often both relatively common and only weakly predictive of later onset of an illness. However, it is important to consider that the level of risk for developing any mental illness associated with these risk factors is typically quite elevated [18]. For example, one meta-analysis reported that approximately half of people with a parent with schizophrenia, bipolar disorder, or depression will develop one of those illnesses by early adulthood [66]. In addition, individuals with familial risk tend to develop more severe symptoms and have an earlier age of onset than average [67, 68]. Similarly, people with a history of childhood maltreatment are approximately twice as likely to develop any mental illness than those without such a history [69]. Thus, several studies have examined the effects of preventive interventions in young people with a relative with a mental illness or substance use disorder, or in those who have experienced abuse, socioeconomic hardships, or traumatic events [21, 70].
Family-focused selective prevention
Many selective prevention interventions have focused on very young children and the family unit, and are often conducted either with the parent/guardian alone or with parent/child dyads. These interventions often focus on a range of goals, including psychoeducation, family therapy, communication skills and coping strategies. One example of this type of program is the Attachment and Biobehavioral Catch-up (ABC) intervention [71]. ABC has been tested in parents of children at risk for maltreatment, with most studies recruiting samples referred to child welfare (due to the potential need to remove the child from the home). It is a 10-week program aiming to prevent later psychopathology in infants up to 2 years old, delivered to the parents of the child. A systematic review of ten ABC RCTs found that ABC was effective in improving emotion regulation, decreasing externalizing and internalizing problems, and even preserving child development timelines in the children [72].
Another selective preventive intervention that has been extensively studied is Parent-Child Interaction Therapy (PCIT), a program for children, age 2-7 years, who have experienced abuse [73]. PCIT focuses on both increasing the levels of attachment between parents/guardians and their children, as well as improving the behavior of the child. Through numerous RCTs, PCIT has shown efficacy not only in reducing externalizing behaviors and preventing developmental delays in the at-risk children, but in preventing childhood maltreatment [74].
In addition, a few selective prevention interventions have been developed for youth with familial risk for psychiatric disorders. The Building Regulation in Dual Generations (BRIDGE) program is delivered to mothers experiencing depression who are currently caring for their 2–5 year-old child [38]. This program teaches these mothers dialectical behavioral skills to improve their mental health, with the ultimate goal of also protecting the mental health of their child [39]. There are strong feasibility and acceptability data for this program, but no published RCTs to date [75].
Other studies focused on children with parents diagnosed with a specific psychiatric condition have typically focused on preventing the occurrence of the same disorder in the child (despite the evidence that this type of familial risk is associated with an increased likelihood of developing a range of psychiatric disorders). For example, several studies have demonstrated the efficacy of group-based CBT delivered to adolescents with a parent with a history of depression in preventing the onset of depression in the adolescents [76,77,78].
Another family-based, selective preventive intervention called Alternatives for Families was designed for children 5-15 years old who have experienced physical abuse. This program focuses on preventing Post-Traumatic Stress Disorder (PTSD) symptoms and disruptive behaviors in these at-risk children, using CBT techniques. Two RCTs conducted with this population found that Alternatives for Families was effective in improving outcomes in both the child (in terms of functioning, anger, depression, aggression and PTSD symptoms) and caregiver (in levels of anger and abusive behavior) up to six months later [79, 80].
Another selective preventive intervention, designed for adolescents, is the World Health Organization’s Early Adolescent Skills for Emotions (EASE) [81]. This intervention is delivered to either the parent, child, or both, and includes seven group-based sessions for the adolescent (10-14 years old), plus two sessions for the parents. When delivered to Burundian refugee families who had been displaced following a violent conflict (and thus at elevated risk for developing psychopathology) [82], EASE was found to improve family relationships and adolescent well-being [83].
Lastly, the Strong African American Families (SAAF) program was designed for African American adolescents and their family members living in communities in the rural American South with high poverty levels [84,85,86]. Youth living in these communities are at elevated risk for later substance abuse and a range of poor health outcomes. The SAAF intervention consists of 7 weekly meetings in community settings focused on improving parenting, strengthening family relationships and youth competencies. One RCT of SAAF, which enrolled 667 African American mothers and their 11-year old children, found that improvements in parenting mediated beneficial effects of SAAF on the children, compared to an assessment-only control group, on a range of protective factors, including attitudes about early alcohol use and sexual activity, a goal-directed future orientation, and acceptance of parental influence, at the 7-month follow-up assessment [84]. In addition, approximately 5 years following the study, alcohol use had increased at a slower rate in the youth who had participated in SAAF compared to the control group [87]. At 8 years following the study, lower levels of peripheral inflammatory markers were observed in a subset of the SAAF participants compared to control group participants, which was partially attributable to improvements in parenting [88]. Thus, such family-based interventions focused on pre-adolescent youth may have long-term, wide-ranging health benefits. However, additional well-controlled trials, which measure psychiatric and physical health outcomes directly, are needed.
Future directions
Selective prevention strategies have been generally under-utilized, despite the elevated transdiagnostic risk for developing mental illnesses associated with a wide range of familial and environmental risk factors. This approach should receive greater investment in the future, particularly since selective prevention approaches may have the advantage, in terms of gaining acceptance by the public, of being easily comparable to prevention strategies used in other fields of medicine, such as those deployed in asymptomatic people who have familial risk for serious medical conditions such as cancer, heart disease and stroke. Public education and the development of a standardized screening approach for these silent mental illness risk factors, combined with safeguards that prevent stigmatizing effects of a “positive” screening result, could lead to wider implementation of this strategy. However, similar to universal preventive interventions, the strength of the effects of these programs may be limited when the risk factor is only weakly predictive of the outcome and the outcome has a low incidence rate. Also, the neuro-psychological mechanisms underlying the vulnerability to mental illness may vary within an at-risk group; consequently, the intervention may benefit only a portion of those at-risk. In light of these limitations, selective preventive behavioral interventions may be more likely to succeed if: 1) the intervention targets multiple psychological mechanisms; 2) the risk factor or combination of risk factors are strongly predictive of a poor outcome; and 3) the outcome is transdiagnostic (increasing the strength of this predictive association).
Indicated prevention
Overview
Indicated prevention strategies in mental health, which focus on individuals who have early, subthreshold symptoms of psychopathology, have been studied and tested extensively. Most of these programs focus on youth with subclinical symptoms of a specific disorder or a category of related disorders. However, although many of the initial studies of preventive interventions with this design were focused on preventing a specific disorder, such as major depression or schizophrenia, many of these interventions likely had broad, transdiagnostic effects. Regardless, our review (below) of indicated prevention interventions is primarily limited to those programs that were explicitly designed to target a transdiagnostically-defined at-risk population and/or outcome(s).
In order to target individuals with transdiagnostically-defined risk factors for mental illnesses [89], studies of indicated preventive interventions have often used a certain threshold score on a general mental health screening instrument, that typically measures a range of symptoms of different psychiatric disorders, or a similar threshold score on a validated personality measure, as the primary eligibility criterion. Participants with scores at or above this threshold, who do not exhibit the severity of symptoms or functional impairment associated with a full syndromal psychiatric illness, are then considered to be at risk for developing an illness.
Transdiagnostically-defined outcomes in these studies are typically: 1) levels of two or more symptom types (e.g., anxiety and depression) and/or 2) behavioral outcomes (e.g., school attendance, overall functioning). These outcomes are assessed via interview, self-report and/or parent report. Notably, very few studies of transdiagnostic, indicated preventive interventions identified the onset of a psychiatric diagnosis as the primary outcome. This is likely due to limitations in resources, since the length of longitudinal follow-up and the sample size needed to observe an effect on a categorical outcome such as illness onset requires a substantial investment of effort that occurs infrequently in mental health prevention research.
It is also important to note that most prevention-oriented behavioral interventions represent minor adaptations of interventions used for the treatment of psychiatric disorders, and this is particularly true for indicated preventive interventions (since they focus on mildly symptomatic individuals), including those that are transdiagnostic. For example, the most extensively-studied transdiagnostic behavioral treatment (used most commonly to treat mood and anxiety disorders) is the Unified Protocol (UP) for Transdiagnostic Treatment of Emotional Disorders (https://unifiedprotocol.com), which is currently available in 11 languages and in individual, group, and digital formats [15, 90]. The UP focuses on emotional awareness, flexible thinking, emotion avoidance, emotion-related physical sensations, and emotion-focused exposure [91] and is undergoing testing as a preventive intervention (with mixed, albeit preliminary, results thus far [92, 93]).
School-based indicated prevention
Similar to universal prevention programs, many indicated prevention interventions have been deployed in primary and secondary schools (K-12), as well as in colleges and universities. One intervention focused on the transdiagnostic prevention of anxiety and mood disorders is the EMOTION program, a CBT-based program for 8–12-year-old children with subsyndromal symptoms of anxiety or depression [94]. In a school-based RCT (with randomization occurring at the school level) conducted with 795 symptomatic children, the children in the EMOTION group showed a significant reduction in their symptoms compared to those enrolled in the control condition (treatment as usual, defined as psychoeducation training of school staff).
As mentioned above, indicated prevention programs often rely on a brief mental health screening process to identify at-risk children experiencing subclinical symptoms of psychopathology. One commonly used screening instrument is the Strengths and Difficulties Questionnaire (SDQ), which assesses emotions, conduct, inattentiveness, peer relationships and prosocial behaviors [95]. One study that used the SDQ to identify at-risk children tested a CBT-based, manualized indicated preventive intervention called Mind My Mind (MMM). This intervention was compared to “management as usual” (MAU, consisting of a choice of counseling, advice, educational support, or no treatment) in an RCT that enrolled 396 at-risk children (ages 6-12, mean: 10 years). Using the SDQ, these children were identified as having symptoms of anxiety, depression or behavioral problems that were still below the threshold needed for a referral to mental health care. Compared to the MAU control condition, the children in the MMM group showed significant improvements in symptoms and functioning as measured by the SDQ (reported by the child), as well as parent-reported outcomes for the child, including depression, anxiety, social functioning, and school attendance, up to 26 weeks later [96].
Another school-based intervention, called Mastermind, has been studied with a single arm design, using the SDQ to identify 80 children (mean age: 12 years) with mild symptoms of psychopathology. These children were enrolled in eight after-school sessions focused on empowerment, self-esteem building and attention bias modification to reduce maladaptive negative thinking. Improvements in self-esteem, anxiety, depressive, and behavioral symptoms occurred following the intervention [97].
A well-studied indicated preventive intervention designed for older adolescents, focused on preventing symptoms of anxiety and depression, is the Structured Material for Therapy (SMART) program, which is a 6-week, 5-module, CBT-based intervention. SMART was studied in a waitlist- controlled RCT of 163 adolescents (mean age: 15.5 years) identified using the SDQ as having mild “emotional problems”. This study found that SMART led to improvements in internalizing symptoms and global functioning at the six months follow-up time point [98].
Personality dimensions have also been used to identify youth who might benefit from an indicated preventive intervention. For example, Preventure is a group-based intervention for adolescents that aims to prevent substance use and psychiatric disorders. An RCT of Preventure used personality dimensions derived from the self-report Substance Use Risk Profile screening battery [99] to identify and enroll 701 students (mean age: 13.4 years) with elevated scores on impulsivity, sensation seeking, negative thinking, and/or anxiety sensitivity. Worsening of psychiatric symptoms was slower in the group that received Preventure up to three years later, compared to a control group which received usual health education [100].
Similarly, an intervention was developed for young adults who were deemed at risk for psychiatric disorders based on a personality assessment. The intervention, called the Personality and Living of University Students (PLUS), is a CBT-based program focused on emotion regulation, self-esteem building, and combating perfectionism, among other goals. In an RCT, 1,047 college students were recruited online based on their scores on a personality instrument (assessing neuroticism, concern with mistakes, doubts about actions, and hopelessness) and were randomized to either receive PLUS or a healthy lifestyle control intervention. Compared to the control, significant improvements were found for those who received PLUS in self-esteem and symptoms of depression and anxiety 12 weeks later [101].
Family-focused indicated prevention
Indicated prevention approaches for youth with subclinical symptoms of psychopathology have also included family-based interventions. For example, Emotion Focused Skills Training (EFST) is a manualized intervention delivered to parents that aims to promote parental self-efficacy and emotion regulation skills in parents and their children. It does this by helping parents manage their own and their children’s emotions, repair relationship ruptures, set boundaries for their child and foster communication within the family, using psychoeducational material plus explicit facilitation of emotion activation, using evocative experiential techniques. When the full EFST program (psychoeducation and emotion activation) was compared to the psychoeducational component alone, with parents of 236 adolescents experiencing internalizing and externalizing symptoms, the full EFST program was not found to be significantly more effective than the psychoeducational component in reducing the children’s symptoms and preventing them from reaching a clinical threshold of symptom severity one year later [102]. However, both the full EFST and psychoeducational component alone were associated with reductions in internalizing and externalizing symptoms in the adolescents at the one year follow-up time point.
Resilience-focused indicated prevention
There are a few indicated preventive interventions that have explicitly focused on measuring and augmenting protective factors, as well as symptom reductions. For example, Resilience Training (RT) is a four-session, mindfulness-based intervention that was designed for young adults experiencing depressive symptoms and/or psychotic experiences (subclinical psychotic-like symptoms) [103]. In a waitlist-controlled RCT conducted in 107 college students, significant increases in resilience-related capacities, including mindfulness, self-compassion and positive affect, as well as significant reductions in symptoms of psychopathology, such as psychotic experiences, depression, anxiety and loneliness, were observed in the young adults who received RT compared to those assigned to the waitlist control group [104, 105] (Fig. 1). Transdiagnostic interventions such as RT that focus on augmenting mental health-promoting capacities, behaviors or intrinsic strengths [58] may have more durable effects, as well as potentially greater appeal to non-help-seeking youth, than interventions that focus solely on reducing symptom-related biases and impairments.
Resilience Training (RT) consists of four 90-minute group sessions that teach young people mindfulness, self-compassion and mentalization skills. In a waitlist-controlled RCT, college students with either subclinical psychotic symptoms or symptoms of depression were randomized to either the active intervention (Resilience Training, RT, n = 54) or a waitlist control condition (No RT, n = 53). Significantly larger increases in resilience-related capacities, such as mindfulness, self-compassion, positive affect and overall resilience (measured using validated self-report scales) were observed in the RT compared to the waitlist condition. In addition, these improvements were associated with the significantly greater decreases in symptoms of psychopathology (depression, anxiety and psychotic experiences), and loneliness observed in the RT compared to the waitlist control condition. See [55, 56] for additional details.
Indicated prevention for youth at risk for serious mental illnesses
In parallel to the large body of research focused on the prevention of internalizing disorders such as depression, there has been a substantial effort focused on developing and testing interventions that may prevent the onset of schizophrenia and related psychotic disorders, primarily in young people with subclinical psychotic symptoms [10]. These programs have most frequently used CBT, sometimes in combination with other treatments [10]. Overall, this body of research has produced mixed results, with limited evidence that these interventions lead to the prevention of psychotic disorders specifically [10, 106]. However, based on the evidence that subclinical psychotic symptoms are associated with elevated risk for the development of a number of psychiatric disorders and poor outcomes [107,108,109], in addition to psychosis, this research effort has now broadened to focus on a wider range of transdiagnostic risk states and outcomes [17, 110, 111]. For example, given that a substantial portion of individuals experiencing risk states defined by the presence of subclinical psychotic symptoms (i.e., the Clinical High Risk (CHR) or Ultra High Risk (UHR) for psychosis syndromes) have comorbid mood or anxiety disorders or develop these disorders over time, and experience varying degrees of functional impairment [112], intervention studies conducted in these populations have begun to include transdiagnostic outcomes.
One recent study of youth meeting criteria for UHR for psychosis which broadened the targeted outcomes beyond psychosis onset is the Staged Treatment in Early Psychosis (STEP) study. This study enrolled 342 UHR for psychosis youth (12-25 years old) in a sequential, multiple assignment randomized trial [111]. In this trial, the UHR participants were randomized to one of two interventions at three stages, advancing to the next stage if there was no treatment response at the prior stage (the interventions included: support and problem solving, CBT-based case management, fish oil, and an antidepressant or antipsychotic medication). The primary (transdiagnostic) outcome was global functioning. UHR remission rates and transition to psychosis were also measured. Possibly due to the high drop-out, low adherence and low fidelity rates in this trial, there were no significant differences between the treatment conditions in effects on the outcomes, for all three intervention stages. The low remission rates in this study are consistent with prior data showing that UHR individuals are often chronically quite symptomatic [112], and thus may not represent ideal targets of primary prevention approaches [65]. However, this trial can provide one overall model for staged-based care of high risk youth that could be employed to test interventions that might have specific effects on candidate psychological or neurobiological mechanisms that are variably affected within heterogeneous at-risk samples.
The clinical staging approach
A related model of care that involves focusing on both: 1) a transdiagnostic at-risk population and 2) transdiagnostic outcomes, is the clinical staging model developed in Australia by McGorry, Hartmann and colleagues. This approach focuses on a broadly defined at-risk syndrome, referred to as the Clinical High At-Risk Mental State (CHARMS), that encompasses clinical risk phenotypes for four disorders: depression, bipolar disorder, borderline personality disorder, and psychosis [110, 113]. This model defines different stages of risk and severity, with Stage 0 including individuals with some form of risk who are without any distress-causing psychopathology, while Stages 1a and 1b require the presence of subsyndromal, distress-causing symptoms (with 1b corresponding to greater syndromal specificity than 1a and includes the CHARMS category). Stages 2-4 indicate the presence of a suprathreshold psychiatric disorder, with varying levels of severity and chronicity. An assumption of this model is that increasing levels of diagnostic specificity (clinical differentiation) emerge as clinical progression occurs across the stages in a subset of those at risk.
One longitudinal study of this staging model found that, of 1,370 youth at Stage 1b, 176 (12.8%) transitioned to a Stage 2 (full-threshold) disorder over a median follow up period of 14 months [114]. Another, smaller study that followed 41 Stage 1a and 80 Stage 1b youth over one year found that 28% of the Stage 1b youth developed a Stage 2 disorder (with 96% developing major depressive disorder), whereas only 9% of the Stage 1a youth transitioned to Stage 2 [110]. These initial findings suggest that the broader inclusion and outcome criteria of this model may be useful (i.e., associated with sufficient power) for testing transdiagnostic prevention approaches. However, potential heterogeneity in the psychological and neurobiological mechanisms associated with the early stages could lead to challenges in identifying specific interventions that consistently modify transition rates. Identifying Stage 1a or 1b individuals that show evidence for altered psychological processes that are shared across different forms of psychopathology [18], and testing interventions that target such processes in these individuals, could represent a rational next step for validating this transdiagnostic staging model.
Combined approaches
Another way to increase statistical power and the potential to observe beneficial effects of a preventive intervention is to enrich the target sample for severity or types of risk. Some transdiagnostic prevention programs have employed this strategy by using several eligibility criteria, so that they essentially represent a combination of selective and indicated prevention strategies. This approach of targeting youth with multiple risk factors for developing psychiatric disorders may prove to be particularly cost effective, given the highly elevated level of transdiagnostic risk observed in these vulnerable populations.
For example, DBT [115] has been studied as a preventive intervention for children with a history of maltreatment (selective prevention); these children often present with a range of symptoms, including suicidal thoughts and behaviors (indicated prevention). DBT has shown effectiveness in preventing depressive symptoms, suicidal thoughts and behaviors, and improving emotion regulation skills in this high risk population [116,117,118].
This type of risk enrichment approach was also used in a study of a preventive intervention currently called Living In Families with Emotions (LIFE), which was developed for adolescents (age 11-14 years) with environmental risk factors (selective prevention), plus subclinical symptoms of psychopathology (indicated prevention). LIFE is a group-based intervention, consisting of eight sessions for the at-risk adolescents and three sessions for the adolescents’ caregivers, which was initially designed for adolescents living in an immigrant community with high levels of poverty and family disruption. The sessions focus on teaching emotion awareness and regulation techniques, as well as social skills. In a one arm pilot trial, enrolled children scored in the subclinical range on a mental health screening survey administered during the child’s annual check-up with their pediatrician. The study found that significant improvements in subclinical symptoms of anxiety and depression, social functioning, and emotion recognition occurred following the intervention [119].
Digital approaches
Recent advances in digital mental health technologies have dramatically impacted the development and implementation of mental health interventions and may be useful for the early detection and prevention of psychiatric illnesses as well, given the importance, in prevention efforts, of minimizing burden and maximizing access. The development and use of smart phone-based applications, ecological momentary interventions, virtual reality (VR)-based programs, and artificial intelligence-enhanced screening approaches are quickly leading to substantial changes in how mental health interventions are conceptualized and delivered [120,121,122,123,124]. These changes include both adaptations of existing in-person interventions for digital delivery and the development of novel digital interventions, as well as hybrid (with digital and non-digital components) programs. Advantages of these programs include their convenience, the ability to tailor them to an individual’s specific needs, and the anonymity that can be provided in some cases. (Below we have described some interventions that have been tested primarily in adults or clinical populations, since they may represent novel approaches that could be applied in at-risk youth in the future, in addition to describing programs designed for youth.)
One digital intervention that was designed to reduce symptoms of anxiety and depression (indicated prevention) is an application that can be used on a range of devices (e.g., smartphone, computer, iPad) called ICare Prevent [125]. This program is comprised of 7 sessions (focused on problem solving, exposure, behavioral activation, psychoeducation, and cognitive restructuring among other topics), plus an additional booster session one month after completion of the 7 sessions. There are also 8 optional sessions focused on topics such as relaxation, substance use, and sleep. An RCT of ICare Prevent with 566 adults experiencing subclinical depression and/or anxiety were randomized to one of three conditions: 1) receiving the intervention with individual guidance (messaging) from a live coach; 2) receiving the intervention with automated guidance (standardized feedback following each session and no individual coaching) or 3) a waitlist. Significant reductions in anxiety and depression were observed in both treatment conditions, compared to the waitlist condition, up to six months later, with no significant differences between the live and automated guidance conditions [126].
An example of a hybrid (digital and non-digital delivery) indicated preventive intervention is the EMIcompass program, which uses an ecological momentary intervention (EMI) with an interactive approach. This program includes both face-to-face sessions and compassion-focused EMI-delivered tasks that participants complete each week using their mobile phone application. In one RCT of this program, EMIcompass was compared to treatment as usual (TAU) in 92 participants (ages 14-25) who were at-risk (with subclinical symptoms) or in the first-episode stage of a psychotic illness. While EMIcompass did not lead to significant improvements in the primary outcome, self-reported distress, stress reactivity was significantly reduced, and quality of life was improved, in the active compared to the TAU condition [127].
It is also important to note that there are several popular commercially available smartphone-based mental health-focused applications, such as Headspace and Calm, that have millions of monthly users [128]; while these applications do not have a specific prevention focus, they are universally available and widely used—thus they could serve as a universal prevention tool. While Calm has yet to be tested via RCTs, several RCTs have been conducted to assess the efficacy of Headspace in different populations, with most showing medium effect sizes in reducing symptoms of depression and anxiety [129].
General considerations and future directions
Comparison of strategies
Universal, selective, and indicated approaches for transdiagnostic prevention of mental illnesses have different strengths and limitations. The potential scalability of universal prevention programs is a key strength of this approach, particularly in light of the ongoing shortage of mental health care providers for youth [130, 131]. Regarding selective prevention, existing evidence suggests that children with histories of early adversity or with parents (or other relatives) with psychiatric disorders are populations that can benefit from prevention-focused interventions delivered early on, when mild stressors or very low levels of subclinical symptoms, or no symptoms, are present. Indicated interventions show the strongest evidence for efficacy, but they may not be feasible in some settings, since mental health screenings (a necessary first step for most indicated prevention programs) can be costly and labor intensive, and stigma or privacy-related concerns can limit their use.
However, in settings where mental health screening has become commonplace and accepted, e.g., in many pediatric/primary care clinics and some schools, indicated preventive interventions could be provided to mildly symptomatic youth if the necessary resources are available, potentially focused on prevention of transdiagnostic outcomes (e.g., need for individual mental health care, behavioral issues, school functioning). Indicated prevention programs may be associated with a higher likelihood, compared to universal and selective prevention approaches, that a substantial portion of the targeted population will benefit from the intervention, since shared psychological mechanisms (e.g., disruptions in emotion regulation, maladaptive cognitive biases) that are affected across individuals with different manifestations of subsyndromal psychopathology can be targeted by these interventions. Although the relative value of these three different strategies has been extensively debated, there is some emerging consensus that a combination of these approaches may provide the most benefit to youth (and society) as a whole [65].
Transdiagnostic functional outcomes
It is somewhat surprising that there have been few studies to date that have measured the effects of preventive interventions on transdiagnostic functional outcomes, such as academic performance, school retention/drop out rates, social functioning, or transitions to college/employment, in addition to measuring symptoms of psychopathology or the onset of a psychiatric illness. Study designs that focus on functioning could capitalize on a shared feature of most categorically-defined psychiatric diagnoses – that they are often distinguished from subclinical states by their detrimental effects on functioning. Thus, maintenance of normative school and social behaviors, and achieving key developmental milestones, could serve as the long-term, “real world” goals of transdiagnostic intervention programs.
Longitudinal studies are needed to assess transdiagnostic endpoints; measuring whether infrequently occuring outcomes, such as the onset of a serious mental illness or a precipitous decline in functioning, emerge over time requires monitoring over an extended period of development. In such studies, understanding the mechanistic relationships between the effects of the intervention on a modifiable risk factor, such as a subclinical symptom of psychopathology or a neurobiological mechanism, and the intervention’s longer-term preventive effects on the targeted clinical or functional outcome, such as the absence of onset of a certain diagnosis, category of diagnoses or functional decline related to a psychiatric condition (see Fig. 2 for an illustration of these relationships) will be necessary for developing targeted, individualized intervention strategies.
This illustration displays predicted changes in the expression of a modifiable risk factor, such as a subclinical symptom, and the longer-term effects of this risk factor, leading to a negative (undesirable) outcome, such as an impairment in functioning or the onset of a psychiatric disorder. In the absence of an intervention (panel a), the expression of the risk factor may increase over time (solid red line) and the negative outcome (functional impairment in this illustration) may emerge at a certain point (solid black line). Above a specific level of functional impairment (purple line), a disorder may be diagnosed. However, following a successful preventive intervention (panel b), the expression of the modifiable risk factor is reduced (dashed red line), and subsequently, at a later point in time, the negative outcome (e.g., functional impairment) is avoided (dashed black line).
Targeting individual-level mechanisms
Future studies may increasingly employ novel, individualized approaches that identify those who are most likely to respond to a given preventive intervention, and provide the skills or strategies that are most likely to be effective at reducing those individuals’ level of risk [132]. As has been suggested previously, progress towards achieving this goal would be accelerated by the validation of biological markers of risk that could be used to determine eligibility for prevention trials, and subsequently used as objective targets of interventions designed to modify that target. Establishing such markers has been an elusive goal of psychiatric neuroscience research for decades. However, some progress has occurred via several lines of research.
First, evidence for a set of common genetic variants that are associated with risk for multiple psychiatric disorders, as well as evidence for changes in the brain that are shared across psychiatric disorders [18], suggest that, ultimately, a “transdiagnostic risk profile” could be generated for individuals. This risk profile could also incorporate transdiagnostic environmental risk factors (e.g., prenatal exposures to toxins or infections, history of early adversity) and psychological features (e.g., aspects of temperament, personality) to identify those with different levels and types of risk.
Second, studies have been conducted which directly measure the effects of interventions on brain functioning, and some of these effects on the brain appear to correlate with symptom improvements associated with the intervention. These intervention-linked changes in brain functioning could be used to identify individuals who are most likely to benefit from an intervention. For example, meta-analyses have found evidence that a range of different types of psychotherapy, including mindfulness-based interventions [133], influence the function and connectivity of the “salience network” of the brain, which includes the anterior insula and dorsal anterior cingulate cortex, particularly in people with internalizing disorders [134, 135]. Effects of psychotherapy on the insula have also been observed in individuals with subthreshold symptoms of depression [136]. In addition, there is evidence that abnormal salience network activity at baseline may predict responses to psychotherapy [137]. These findings are particularly notable in light of evidence that the salience network may represent a common (transdiagnostic) site of changes in brain structure and function observed across multiple psychiatric disorders [18, 138,139,140]. Thus, future prevention trials could target individuals with non-specific risk factors for mental illness who also show changes in the salience network, to test whether a preventive behavioral intervention could modify these changes and risk for psychopathology. This strategy is broadly consistent with the mechanism-focused, “experimental therapeutics” approach to clinical trials that has been advocated by the National Institute of Mental Health [141].
Mindfulness intervention-related changes have also been observed in the functional connectivity between: 1) the default mode network, which is involved in self-awareness and introspection, and 2) brain networks that support cognitive control and interoceptive awareness (the central executive control and salience networks) [142, 143]. These circuits are involved in emotional regulation, among other functions [144,145,146,147], which may account for the changes observed in these networks following acquisition of mindfulness-related skills. An example of this type of finding is preliminary evidence for a link between 1) a reduction in emotion reactivity and 2) an increase in the functional connectivity between the hippocampus (a component of the default network) and the dorsolateral prefrontal cortex (a region involved in emotion regulation and cognitive control) in at-risk young adults following a mindfulness-based intervention [148].
In summary, these findings generally suggest that neuroimaging-based (or related behavioral) markers should be tested further for their utility in identifying individuals within at-risk populations, that are initially characterized by non-specific risk factors (e.g., a family history of mental illness, childhood adversity, mild subsyndromal symptoms), who could most benefit from preventive interventions that engage the relevant neural circuits.
Depression as a broadly transdiagnostic target
Another potential next step in the overall effort to identify effective transdiagnostic prevention strategies is to re-purpose what is already known about treating and preventing certain common forms of psychopathology, using a transdiagnostic lens. For example, meta-analyses have established that major depressive disorder can be prevented in a portion of at-risk individuals using psychological [149,150,151] and exercise [152, 153] interventions. Also, numerous lines of research have shown that, across different individuals, depression can represent either an endpoint (the final stage of the evolution of a mental illness for an at-risk individual) or an intermediate stage along a trajectory towards the development of another chronic mental illness such as bipolar disorder or schizophrenia [154,155,156,157,158]. Similarly, anxiety in children and adolescents has been linked to an increased risk for the later development of a range of psychiatric disorders [159, 160], thus could also serve as a marker of an intermediate stage of transdiagnostic risk for mental illnesses for some individuals. This is consistent with the fact that certain cognitive or affective traits associated with depression and anxiety, such as negative attribution biases, are common in the general population and confer risk for multiple psychiatric disorders. Thus, targeting depression, internalizing symptoms (depression and anxiety), or cognitive styles associated with these symptoms, could represent a transdiagnostic prevention strategy that may be effective in reducing risk for multiple psychiatric conditions.
Systemic and developmental considerations
Overall, a great need remains for evidence-based transdiagnostic preventive interventions that are proven to be scalable, minimally burdensome, and can engage young people “where they are” both literally (i.e., in spaces where youth spend their time) and culturally (using youth-friendly language, images, activities and technology). Several pioneering examples of successful community-based youth mental health programs [161,162,163] have begun to demonstrate the feasibility of these types of approaches. In addition, some primary care programs have expanded to provide mental health services, and, while most of these programs do not deliver a specific mental health-focused intervention, they tend to serve a wide range of youth and provide mental health assessments along with medical care [164]. For example, the “headspace” program, which has more than 65 sites in Australia, combines primary care with mental health-related (indicated) preventive interventions for youth who may be at risk for a mental illness [165], offering multiple avenues of care, ranging from phone hotlines that provide access to a clinician, to support for those seeking employment, individual mental health treatment, and family services.
To maximize retention of youth in prevention-focused programs, consideration of the developmental stage (e.g., the education level and psychological capacities) of the youth is important when designing the content and structure of interventions, including decisions about the length of sessions, number of breaks, degree of parent/caregiver involvement, and the overall strategy for recruitment. For example, there is some evidence that the effectiveness of preventive interventions in youth is enhanced by parental involvement [166,167,168]. On the other hand, older adolescents may be reluctant to participate in a program that involves their parents [169]. For young adults, typically their engagement and some degree of immediate benefit from an intervention must be substantial in order to maintain their participation, since their time and attention is often consumed by a variety of social, academic and online activities and, unlike children and adolescents, they have the autonomy to choose (or decline) to participate in a mental health program. Also, given that subclinical psychopathology may become more differentiated (less transdiagnostic) in some at-risk youth over time, the need for indicated interventions may become greater during late adolescence/early adulthood, whereas universal interventions may be most impactful for pre-adolescent children [170]. However, these and other developmental considerations require further study.
Shifting public opinion
Further education of the public and policy makers regarding the value of screening and tiered prevention programs for enhancing youth mental health is greatly needed to accelerate progress. Highlighting similarities to successful prevention programs employed in other fields of medicine may provide an initial rationale for investing resources in avoiding, interrupting, or slowing the progression of mental illnesses in vulnerable young people. As increasingly rigorous and well-powered trials are conducted, a strong empirical justification and related motivation for disseminating routine preventive mental health care for youth may grow over time.
References
Gunnell D, Kidger J, Elvidge H Adolescent mental health in crisis. BMJ. 2018:k2608.
Kuehn BM. Clinician Shortage Exacerbates Pandemic-Fueled “Mental Health Crisis”. Jama. 2022;327:2179–81.
Satiani A, Niedermier J, Satiani B, Svendsen DP. Projected Workforce of Psychiatrists in the United States: A Population Analysis. Psychiatr Serv. 2018;69:710–3.
Hoare E, Collins S, Marx W, Callaly E, Moxham-Smith R, Cuijpers P, et al. Universal depression prevention: An umbrella review of meta-analyses. J Psychiatr Res. 2021;144:483–93.
Schwartz C, Barican JL, Yung D, Zheng Y, Waddell C. Six decades of preventing and treating childhood anxiety disorders: a systematic review and meta-analysis to inform policy and practice. Evid Based Ment Health. 2019;22:103–10.
Stice E, Onipede ZA, Marti CN. A meta-analytic review of trials that tested whether eating disorder prevention programs prevent eating disorder onset. Clin Psychol Rev. 2021;87:102046.
Sangsawang B, Wacharasin C, Sangsawang N. Interventions for the prevention of postpartum depression in adolescent mothers: a systematic review. Arch Women’s Ment Health. 2019;22:215–28.
Chen C, Wang X, Xu H, Li Y. Effectiveness of digital psychological interventions in reducing perinatal depression: a systematic review of meta-analyses. Arch Women’s Ment Health. 2023;26:423–39.
Tremblay M, Baydala L, Khan M, Currie C, Morley K, Burkholder C, et al. Primary Substance Use Prevention Programs for Children and Youth: A Systematic Review. Pediatrics. 2020;146.
Fusar-Poli P, Salazar de Pablo G, Correll CU, Meyer-Lindenberg A, Millan MJ, Borgwardt S, et al. Prevention of Psychosis: Advances in Detection, Prognosis, and Intervention. JAMA psychiatry. 2020;77:755.
McGorry PD, Hartmann JA, Spooner R, Nelson B. Beyond the “at risk mental state” concept: transitioning to transdiagnostic psychiatry. World psychiatry : Off J World Psychiatr Assoc (WPA). 2018;17:133–42.
Knapp M, McDaid D, Parsonage M Mental health promotion and mental illness prevention: the economic case. London, UK: Department of Health; 2011 2011.
McDaid D, Park AL, Wahlbeck K. The Economic Case for the Prevention of Mental Illness. Annual Rev Public Health. 2019;40:373–89.
McCrone P. Debate: Where to next for universal school-based mental health interventions? Universal versus targeted school-based mental health interventions: a health economic perspective. Child Adolesc Ment Health. 2025;30:99–101.
Barlow DH, Ellard KK, Fairholme CP Unified protocol for transdiagnostic treatment of emotional disorders. Press OU, editor2010.
Cuijpers P. Examining the effects of prevention programs on the incidence of new cases of mental disorders: the lack of statistical power. Am J Psychiatry. 2003;160:1385–91.
Hartmann JA, McGorry PD, Destree L, Amminger GP, Chanen AM, Davey CG, et al. Pluripotential Risk and Clinical Staging: Theoretical Considerations and Preliminary Data From a Transdiagnostic Risk Identification Approach. Front Psychiatry. 2020;11:553578.
Holt DJ, Choi KW, DeTore NR, Balogun O Transdiagnostic prevention in youth mental health, Part I: rationale, shared risk factors. Neuropsychopharmacology Reviews. 2025.
Kennedy KP, Alexander JL, Garakani A, Gross LS, Mintz DL, Parikh T, et al. Vitamin B(12) Supplementation in Psychiatric Practice. Curr Psychiatry Rep. 2024;26:265–72.
Guu TW, Mischoulon D, Sarris J, Hibbeln J, McNamara RK, Hamazaki K, et al. International Society for Nutritional Psychiatry Research Practice Guidelines for Omega-3 Fatty Acids in the Treatment of Major Depressive Disorder. Psychother Psychosom. 2019;88:263–73.
Shenk CE, Keeshin B, Bensman HE, Olson AE, Allen B. Behavioral and pharmacological interventions for the prevention and treatment of psychiatric disorders with children exposed to maltreatment. Pharmacol Biochem Behav. 2021;211:173298.
Gordon RS Jr. An operational classification of disease prevention. Public Health Rep. 1983;98:107–9.
Scott J, Iorfino F, Capon W, Crouse J, Nelson B, Chanen AM, et al. Staging 2.0: refining transdiagnostic clinical staging frameworks to enhance reliability and utility for youth mental health. Lancet Psychiatry. 2024;11:461–71.
Kessler RC, Berglund P, Demler O, Jin R, Merikangas KR, Walters EE. Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry. 2005;62:593–602.
Jacka FN, Reavley NJ, Jorm AF, Toumbourou JW, Lewis AJ, Berk M. Prevention of common mental disorders: What can we learn from those who have gone before and where do we go next?. Australian NZ J Psychiatry. 2013;47:920–9.
Rose GA, Khaw KT, Marmot M Rose’s strategy of preventive medicine: the complete original text. USA: Oxford University Press; 2008.
Kessler RC, Avenevoli S, Costello EJ, Georgiades K, Green JG, Gruber MJ, et al. Prevalence, persistence, and sociodemographic correlates of DSM-IV disorders in the National Comorbidity Survey Replication Adolescent Supplement. Arch Gen Psychiatry. 2012;69:372–80.
Caspi A, Houts RM, Ambler A, Danese A, Elliott ML, Hariri A, et al. Longitudinal Assessment of Mental Health Disorders and Comorbidities Across 4 Decades Among Participants in the Dunedin Birth Cohort Study. JAMA Netw Open. 2020;3:e203221.
Stallard P, Skryabina E, Taylor G, Phillips R, Daniels H, Anderson R, et al. Classroom-based cognitive behaviour therapy (FRIENDS): a cluster randomised controlled trial to Prevent Anxiety in Children through Education in Schools (PACES). Lancet Psychiatry. 2014;1:185–92.
Wasserman D, Hoven CW, Wasserman C, Wall M, Eisenberg R, Hadlaczky G, et al. School-based suicide prevention programmes: the SEYLE cluster-randomised, controlled trial. Lancet. 2015;385:1536–44.
Kraag G, Van Breukelen GJ, Kok G, Hosman C. Learn Young, Learn Fair’, a stress management program for fifth and sixth graders: longitudinal results from an experimental study. J Child Psychol Psychiatry. 2009;50:1185–95.
Fraguas D, Díaz-Caneja CM, Ayora M, Durán-Cutilla M, Abregú-Crespo R, Ezquiaga-Bravo I, et al. Assessment of School Anti-Bullying Interventions: A Meta-analysis of Randomized Clinical Trials. JAMA Pediatr. 2021;175:44–55.
Cuijpers P. Indirect Prevention and Treatment of Depression: An Emerging Paradigm?. Clin Psychol Eur. 2021;3:e6847.
Fenwick-Smith A, Dahlberg EE, Thompson SC. Systematic review of resilience-enhancing, universal, primary school-based mental health promotion programs. BMC Psychol. 2018;6:30.
Embry DD. The Good Behavior Game: a best practice candidate as a universal behavioral vaccine. Clin Child Fam Psychol Rev. 2002;5:273–97.
Joslyn PR, Donaldson JM, Austin JL, Vollmer TR. The Good Behavior Game: A brief review. J Appl Behav Anal. 2019;52:811–5.
Barrish HH, Saunders M, Wolf MM. Good behavior game: effects of individual contingencies for group consequences on disruptive behavior in a classroom. J Appl Behav Anal. 1969;2:119–24.
Kellam SG, Rebok GW, Ialongo N, Mayer LS. The course and malleability of aggressive behavior from early first grade into middle school: results of a developmental epidemiologically-based preventive trial. J Child Psychol Psychiatry. 1994;35:259–81.
Kellam SG, Brown CH, Poduska JM, Ialongo NS, Wang W, Toyinbo P, et al. Effects of a universal classroom behavior management program in first and second grades on young adult behavioral, psychiatric, and social outcomes. Drug Alcohol Depend. 2008;95:S5–s28.
Maynard B, Solis M, Miller V, Brendel K. Mindfulness-based interventions for improving cognition, academic achievement, behavior, and socioemotional functioning of primary and secondary school students. Campbell Syst Rev. 2017;13:1–144.
Kuyken W, Ball S, Crane C, Ganguli P, Jones B, Montero-Marin J, et al. Effectiveness and cost-effectiveness of universal school-based mindfulness training compared with normal school provision in reducing risk of mental health problems and promoting well-being in adolescence: the MYRIAD cluster randomised controlled trial. Evid Based Ment Health. 2022;25:99–109.
Montero-Marin J, Allwood M, Ball S, Crane C, De Wilde K, Hinze V, et al. School-based mindfulness training in early adolescence: what works, for whom and how in the MYRIAD trial?. Evid Based Ment Health. 2022;25:117–24.
Guzman-Holst C, Streckfuss Davis R, Andrews JL, Foulkes L Scoping review: potential harm from school-based group mental health interventions. Child Adolesc Ment Health. 2025.
Teesson M, Newton NC, Slade T, Chapman C, Birrell L, Mewton L, et al. Combined prevention for substance use, depression, and anxiety in adolescence: a cluster-randomised controlled trial of a digital online intervention. Lancet Digit Health. 2020;2:e74–e84.
Teesson M, Birrell L, Slade T, Mewton LR, Olsen N, Hides L, et al. Effectiveness of a universal, school-based, online programme for the prevention of anxiety, depression, and substance misuse among adolescents in Australia: 72-month outcomes from a cluster-randomised controlled trial. Lancet Digit Health. 2024;6:e334–e44.
Andrews JL, Birrell L, Chapman C, Teesson M, Newton N, Allsop S, et al. Evaluating the effectiveness of a universal eHealth school-based prevention programme for depression and anxiety, and the moderating role of friendship network characteristics. Psychol Med. 2023;53:5042–51.
Duong MT, Bruns EJ, Lee K, Cox S, Coifman J, Mayworm A, et al. Rates of Mental Health Service Utilization by Children and Adolescents in Schools and Other Common Service Settings: A Systematic Review and Meta-Analysis. Adm Policy Ment Health. 2021;48:420–39.
Bates SM, Anderson-Butcher D, Wolfe T, Ondrus C, Delaney S, Marschhausen J, et al. Grow Your Own School Mental Health Specialists: A Policy Pilot to Address Behavioral Health Workforce Shortages in Schools. Behav Sci (Basel). 2024;14.
Werner-Seidler A, Spanos S, Calear AL, Perry Y, Torok M, O’Dea B, et al. School-based depression and anxiety prevention programs: An updated systematic review and meta-analysis. Clin Psychol Rev. 2021;89:102079.
Shinde S, Weiss HA, Varghese B, Khandeparkar P, Pereira B, Sharma A, et al. Promoting school climate and health outcomes with the SEHER multi-component secondary school intervention in Bihar, India: a cluster-randomised controlled trial. Lancet. 2018;392:2465–77.
Cuijpers P. Universal prevention of depression at schools: dead end or challenging crossroad?. Evid Based Ment Health. 2022;25:96–8.
Birrell L, Grummitt L, Smout S, Maulik P, Teesson M, Newton N. Debate: Where to next for universal school-based mental health interventions?. Child Adolesc Ment Health. 2025;30:92–5.
Andrews JL, Foulkes L. Debate: Where to next for universal school-based mental health interventions? Time to move towards more effective alternatives. Child Adolesc Ment Health. 2025;30:102–4.
Coetzee B, Loades M. Debate: Where to next for universal school-based mental health interventions? Addressing the mental health crisis among young people in low- and middle-income countries. Child Adolesc Ment Health. 2025;30:105–7.
Bogaert L, Van der Gucht K, Kuppens P, Kock M, Schreuder MJ, Kuyken W, et al. The effect of universal school-based mindfulness on anhedonia and emotional distress and its underlying mechanisms: A cluster randomised controlled trial via experience sampling in secondary schools. Behav Res Ther. 2023;169:104405.
Wang P, Wang Z, Qiu S. Universal, school-based transdiagnostic interventions to promote mental health and emotional wellbeing: a systematic review. Child Adolesc Psychiatry Ment Health. 2024;18:47.
Bradshaw M, Gericke H, Coetzee BJ, Stallard P, Human S, Loades M. Universal school-based mental health programmes in low- and middle-income countries: A systematic review and narrative synthesis. Prev Med. 2021;143:106317.
Brodeur S, Oliver D, Ahmed MS, Radua J, Venables J, Gao Y, et al. Why we need to pursue both universal and targeted prevention to reduce the incidence of affective and psychotic disorders: Systematic review and meta-analysis. Neurosci Biobehav Rev. 2024;161:105669.
Mackenzie K, Williams C. Universal, school-based interventions to promote mental and emotional well-being: what is being done in the UK and does it work? A systematic review. BMJ Open. 2018;8:e022560.
Cuijpers P. Preventing the Onset of Depressive Disorders: State of the Art and Future Directions. Current Directions Psychological Sci. 2024;34:51–6.
Johnstone KM, Kemps E, Chen J. A Meta-Analysis of Universal School-Based Prevention Programs for Anxiety and Depression in Children. Clin Child Fam Psychol Rev. 2018;21:466–81.
Salazar de Pablo G, De Micheli A, Solmi M, Oliver D, Catalan A, Verdino V, et al. Universal and Selective Interventions to Prevent Poor Mental Health Outcomes in Young People: Systematic Review and Meta-analysis. Harv Rev Psychiatry. 2021;29:196–215.
Brown J, James K, Lisk S, Shearer J, Byford S, Stallard P, et al. Clinical effectiveness and cost-effectiveness of a brief accessible cognitive behavioural therapy programme for stress in school-aged adolescents (BESST): a cluster randomised controlled trial in the UK. Lancet Psychiatry. 2024;11:504–15.
Tran TD, Nguyen H, Shochet I, Nguyen N, La N, Wurfl A, et al. School-based universal mental health promotion intervention for adolescents in Vietnam: Two-arm, parallel, controlled trial. Glob Ment Health (Camb. 2023;10:e69.
Fusar-Poli P, Correll CU, Arango C, Berk M, Patel V, Ioannidis JPA. Preventive psychiatry: a blueprint for improving the mental health of young people. World psychiatry : Off J World Psychiatr Assoc (WPA). 2021;20:200–21.
Rasic D, Hajek T, Alda M, Uher R. Risk of mental illness in offspring of parents with schizophrenia, bipolar disorder, and major depressive disorder: a meta-analysis of family high-risk studies. Schizophr Bull. 2014;40:28–38.
van Sprang ED, Maciejewski DF, Milaneschi Y, Elzinga BM, Beekman ATF, Hartman CA, et al. Familial risk for depressive and anxiety disorders: associations with genetic, clinical, and psychosocial vulnerabilities. Psychol Med. 2022;52:696–706.
Lawrence PJ, Murayama K, Creswell C. Systematic Review and Meta-Analysis: Anxiety and Depressive Disorders in Offspring of Parents With Anxiety Disorders. J Am Acad Child Adolesc Psychiatry. 2019;58:46–60.
McKay MT, Cannon M, Chambers D, Conroy RM, Coughlan H, Dodd P, et al. Childhood trauma and adult mental disorder: A systematic review and meta-analysis of longitudinal cohort studies. Acta Psychiatr Scand. 2021;143:189–205.
Bröning S, Kumpfer K, Kruse K, Sack PM, Schaunig-Busch I, Ruths S, et al. Selective prevention programs for children from substance-affected families: a comprehensive systematic review. Subst Abus Treat Prev Policy. 2012;7:23.
Dozier M, Peloso E, Lindhiem O, Gordon MK, Manni M, Sepulveda S. Developing evidence-based interventions for foster children: An example of a randomized clinical trial with infants and toddlers. Journal Soc Issues. 2006;62:765–83.
Grube WA, Liming KW. ATTACHMENT AND BIOBEHAVIORAL CATCH-UP: A SYSTEMATIC REVIEW. Infant Ment Health J. 2018;39:656–73.
Funderburk B, Eyberg S Parent-Child Interaction Therapy. In: Norcross J, VandenBos G, Freedheim D, editors. History of Psychotherapy: Continuity and Change. Washington, DC American Psychological Association; 2011. p. 415–20.
Lieneman CC, Brabson LA, Highlander A, Wallace NM, McNeil CB. Parent-Child Interaction Therapy: current perspectives. Psychol Res Behav Manag. 2017;10:239–56.
Roos LE, Kaminski L, Stienwandt S, Hunter S, Giuliano R, Mota N, et al. The Building Regulation in Dual-Generations Program (BRIDGE): A Mixed-Methods Feasibility Pilot of a Parenting Program for Depressed Mothers of Preschoolers, Matched with Dialectical Behavior Therapy Skills. Child Psychiatry Hum Dev. 2023;54:34–50.
Clarke GN, Hornbrook M, Lynch F, Polen M, Gale J, Beardslee W, et al. A randomized trial of a group cognitive intervention for preventing depression in adolescent offspring of depressed parents. Arch Gen Psychiatry. 2001;58:1127–34.
Garber J, Clarke GN, Weersing VR, Beardslee WR, Brent DA, Gladstone TRG, et al. Prevention of Depression in At-Risk Adolescents: A Randomized Controlled Trial. JAMA. 2009;301:2215.
Beardslee WR, Brent DA, Weersing VR, Clarke GN, Porta G, Hollon SD, et al. Prevention of depression in at-risk adolescents: longer-term effects. JAMA psychiatry. 2013;70:1161–70.
Kolko DJ, Iselin AM, Gully KJ. Evaluation of the sustainability and clinical outcome of Alternatives for Families: A Cognitive-Behavioral Therapy (AF-CBT) in a child protection center. Child Abus Negl. 2011;35:105–16.
Kolko DJ, Herschell AD, Baumann BL, Hart JA, Wisniewski SR. AF-CBT for Families Experiencing Physical Aggression or Abuse Served by the Mental Health or Child Welfare System: An Effectiveness Trial. Child Maltreat. 2018;23:319–33.
Dawson KS, Watts S, Carswell K, Shehadeh MH, Jordans MJD, Bryant RA, et al. Improving access to evidence-based interventions for young adolescents: Early Adolescent Skills for Emotions (EASE). World psychiatry : Off J World Psychiatr Assoc (WPA). 2019;18:105–7.
Reed RV, Fazel M, Jones L, Panter-Brick C, Stein A. Mental health of displaced and refugee children resettled in low-income and middle-income countries: risk and protective factors. Lancet. 2012;379:250–65.
Fine SL, Malik A, Guimond MF, Nemiro A, Temu G, Likindikoki S, et al. Improving mental health in low-resource settings: A feasibility randomized controlled trial of a transdiagnostic psychological intervention among Burundian refugee adolescents and their caregivers. Behav Res Ther. 2021;145:103944.
Brody GH, Murry VM, Gerrard M, Gibbons FX, Molgaard V, McNair L, et al. The Strong African American Families Program: translating research into prevention programming. Child Dev. 2004;75:900–17.
Brody GH, Murry VM, Gerrard M, Gibbons FX, McNair L, Brown AC, et al. The strong African American families program: prevention of youths’ high-risk behavior and a test of a model of change. J Fam Psychol. 2006;20:1–11.
Brody GH, Kogan SM, Chen YF, McBride Murry V. Long-term effects of the strong African American families program on youths’ conduct problems. J Adolesc Health. 2008;43:474–81.
Brody GH, Murry VM, Kogan SM, Gerrard M, Gibbons FX, Molgaard V, et al. The Strong African American Families Program: a cluster-randomized prevention trial of long-term effects and a mediational model. J Consult Clin Psychol. 2006;74:356–66.
Miller GE, Brody GH, Yu T, Chen E. A family-oriented psychosocial intervention reduces inflammation in low-SES African American youth. Proc Natl Acad Sci USA. 2014;111:11287–92.
Eaton WW, Badawi M, Melton B. Prodromes and precursors: epidemiologic data for primary prevention of disorders with slow onset. Am J Psychiatry. 1995;152:967–72.
Carlucci L, Saggino A, Balsamo M. On the efficacy of the unified protocol for transdiagnostic treatment of emotional disorders: A systematic review and meta-analysis. Clin Psychol Rev. 2021;87:101999.
Barlow DH, Farchione TJ, Bullis JR, Gallagher MW, Murray-Latin H, Sauer-Zavala S, et al. The Unified Protocol for Transdiagnostic Treatment of Emotional Disorders Compared With Diagnosis-Specific Protocols for Anxiety Disorders: A Randomized Clinical Trial. JAMA psychiatry. 2017;74:875.
García-Escalera J, Valiente RM, Sandín B, Ehrenreich-May J, Prieto A, Chorot P. The Unified Protocol for Transdiagnostic Treatment of Emotional Disorders in Adolescents (UP-A) Adapted as a School-Based Anxiety and Depression Prevention Program: An Initial Cluster Randomized Wait-List-Controlled Trial. Behav Ther. 2020;51:461–73.
Peláez T, López-Carrilero R, Espinosa V, Balsells S, Ochoa S, Osma J. Efficacy of the unified protocol for transdiagnostic treatment of comorbid emotional disorders in patients with ultra high risk for psychosis: Results of a randomized controlled trial. J Affect Disord. 2024;367:934–43.
Martinsen KD, Rasmussen LMP, Wentzel-Larsen T, Holen S, Sund AM, Løvaas MES, et al. Prevention of anxiety and depression in school children: Effectiveness of the transdiagnostic EMOTION program. J Consult Clin Psychol. 2019;87:212–9.
Goodman R, Meltzer H, Bailey V. The Strengths and Difficulties Questionnaire: a pilot study on the validity of the self-report version. Int Rev Psychiatry. 2003;15:173–7.
Jeppesen P, Wolf RT, Nielsen SM, Christensen R, Plessen KJ, Bilenberg N, et al. Effectiveness of Transdiagnostic Cognitive-Behavioral Psychotherapy Compared With Management as Usual for Youth With Common Mental Health Problems: A Randomized Clinical Trial. JAMA psychiatry. 2021;78:250–60.
El Bouhaddani S, Veling W, Schaefer B, Doreleijers T, van Domburgh L. Transdiagnostic school-based intervention for adolescents with early persistent psychiatric symptoms: An initial single-group effect study. Early Inter Psychiatry. 2019;13:1199–207.
Lorentzen V, Fagermo K, Handegård BH, Neumer SP, Skre I. Long-term effectiveness and trajectories of change after treatment with SMART, a transdiagnostic CBT for adolescents with emotional problems. BMC Psychol. 2022;10:167.
Blanchard BE, Stevens AK, Sher KJ, Littlefield AK. Reexamining the Psychometric Properties of the Substance Use Risk Profile Scale. Assessment. 2020;27:454–71.
Lynch SJ, Chapman C, Sunderland M, Slade T, Teesson M, Conrod PJ, et al. The 3-year effects of a personality-targeted prevention program on general and specific dimensions of psychopathology. Prev Med. 2023;173:107595.
Musiat P, Conrod P, Treasure J, Tylee A, Williams C, Schmidt U. Targeted prevention of common mental health disorders in university students: randomised controlled trial of a transdiagnostic trait-focused web-based intervention. PLoS One. 2014;9:e93621.
Ansar N, Nissen Lie HA, Zahl-Olsen R, Bertelsen TB, Elliott R, Stiegler JR. Efficacy of Emotion-Focused Parenting Programs for Children’s Internalizing and Externalizing Symptoms: A Randomized Clinical Study. J Clin Child Adolesc Psychol. 2022;51:923–39.
Burkett JP, Young LJ The behavioral, anatomical and pharmacological parallels between social attachment, love and addiction. Psychopharmacology (Berl). 2012.
DeTore NR, Luther L, Deng WY, Zimmerman JE, Leathem L, Burke A, et al. Efficacy of a transdiagnostic, prevention-focused program for at-risk young adults: A waitlist-controlled trial. Psychological Medicine. 2022.
DeTore NR, Burke A, Nyer M, Holt DJ. A Brief Resilience-Enhancing Intervention and Loneliness in At-Risk Young Adults: A Secondary Analysis of a Randomized Clinical Trial. JAMA Netw Open. 2024;7:e2354728.
Mei C, van der Gaag M, Nelson B, Smit F, Yuen HP, Berger M, et al. Preventive interventions for individuals at ultra high risk for psychosis: An updated and extended meta-analysis. Clinical Psychol Rev. 2021;86:102005.
Varghese D, Scott J, Welham J, Bor W, Najman J, O’Callaghan M, et al. Psychotic-Like Experiences in Major Depression and Anxiety Disorders: A Population-Based Survey in Young Adults. Schizophrenia Bull. 2011;37:389–93.
Oh H, Koyanagi A, Kelleher I, DeVylder J. Psychotic experiences and disability: Findings from the Collaborative Psychiatric Epidemiology Surveys. Schizophrenia Res. 2018;193:343–7.
Yates K, Lång U, Cederlöf M, Boland F, Taylor P, Cannon M, et al. Association of Psychotic Experiences With Subsequent Risk of Suicidal Ideation, Suicide Attempts, and Suicide Deaths: A Systematic Review and Meta-analysis of Longitudinal Population Studies. JAMA psychiatry. 2019;76:180–9.
Destrée L, McGorry P, Chanen A, Ratheesh A, Davey C, Polari A, et al. Transdiagnostic risk identification: A validation study of the Clinical High At Risk Mental State (CHARMS) criteria. Psychiatry Res. 2024;333:115745.
McGorry PD, Mei C, Amminger GP, Yuen HP, Kerr M, Spark J, et al. A Sequential Adaptive Intervention Strategy Targeting Remission and Functional Recovery in Young People at Ultrahigh Risk of Psychosis: The Staged Treatment in Early Psychosis (STEP) Sequential Multiple Assignment Randomized Trial. JAMA psychiatry. 2023;80:875–85.
Solmi M, Soardo L, Kaur S, Azis M, Cabras A, Censori M, et al. Meta-analytic prevalence of comorbid mental disorders in individuals at clinical high risk of psychosis: the case for transdiagnostic assessment. Mol Psychiatry. 2023.
Hartmann JA, Nelson B, Spooner R, Paul Amminger G, Chanen A, Davey CG, et al. Broad clinical high-risk mental state (CHARMS): Methodology of a cohort study validating criteria for pluripotent risk. Early Inter Psychiatry. 2019;13:379–86.
Iorfino F, Scott EM, Carpenter JS, Cross SP, Hermens DF, Killedar M, et al. Clinical Stage Transitions in Persons Aged 12 to 25 Years Presenting to Early Intervention Mental Health Services With Anxiety, Mood, and Psychotic Disorders. JAMA psychiatry. 2019;76:1167–75.
Linehan MM Cognitive-behavioral treatment of borderline personality disorder: Guilford Press; 1993.
Glenn CR, Esposito EC, Porter AC, Robinson DJ. Evidence Base Update of Psychosocial Treatments for Self-Injurious Thoughts and Behaviors in Youth. J Clin Child Adolesc Psychol. 2019;48:357–92.
Mehlum L, Tørmoen AJ, Ramberg M, Haga E, Diep LM, Laberg S, et al. Dialectical behavior therapy for adolescents with repeated suicidal and self-harming behavior: a randomized trial. J Am Acad Child Adolesc Psychiatry. 2014;53:1082–91.
Mehlum L, Ramberg M, Tørmoen AJ, Haga E, Diep LM, Stanley BH, et al. Dialectical Behavior Therapy Compared With Enhanced Usual Care for Adolescents With Repeated Suicidal and Self-Harming Behavior: Outcomes Over a One-Year Follow-Up. J Am Acad Child Adolesc Psychiatry. 2016;55:295–300.
Clauss JA, Bhiku K, Burke A, Pimentel-Diaz Y, DeTore NR, Zapetis S, et al. Development of a transdiagnostic, resilience-focused intervention for at-risk adolescents. Journal Ment health (Abingdon, Engl). 2023;32:592–601.
Holt DJ, DeTore NR, Aideyan B, Utter L, Vinke L, Johnson DS, et al. Enhancing social functioning using multi-user, immersive virtual reality. Sci Rep. 2025;15:2790.
Alvarez-Jimenez M, Rice S, D’Alfonso S, Leicester S, Bendall S, Pryor I, et al. A Novel Multimodal Digital Service (Moderated Online Social Therapy+) for Help-Seeking Young People Experiencing Mental Ill-Health: Pilot Evaluation Within a National Youth E-Mental Health Service. J Med Internet Res. 2020;22:e17155.
Zagni B, Van Ryzin MJ. Technology-supported cooperative learning as a universal mental health intervention in middle and high school. Br J Educ Psychol. 2024;94:792–808.
Bergin AD, Vallejos EP, Davies EB, Daley D, Ford T, Harold G, et al. Preventive digital mental health interventions for children and young people: a review of the design and reporting of research. NPJ Digit Med. 2020;3:133.
Ebert DD, Cuijpers P, Muñoz RF, Baumeister H. Prevention of Mental Health Disorders Using Internet- and Mobile-Based Interventions: A Narrative Review and Recommendations for Future Research. Front Psychiatry. 2017;8:116.
Weisel KK, Zarski AC, Berger T, Krieger T, Schaub MP, Moser CT, et al. Efficacy and cost-effectiveness of guided and unguided internet- and mobile-based indicated transdiagnostic prevention of depression and anxiety (ICare Prevent): A three-armed randomized controlled trial in four European countries. Internet Inter. 2019;16:52–64.
Zarski AC, Weisel KK, Berger T, Krieger T, Schaub MP, Berking M, et al. Efficacy of an Internet- and Mobile-Based Intervention for Subclinical Anxiety and Depression (ICare Prevent) with Two Guidance Formats: Results from a Three-Armed Randomized Controlled Trial. Psychother Psychosom. 2024;93:155–68.
Reininghaus U, Paetzold I, Rauschenberg C, Hirjak D, Banaschewski T, Meyer-Lindenberg A, et al. Effects of a Novel, Transdiagnostic Ecological Momentary Intervention for Prevention, and Early Intervention of Severe Mental Disorder in Youth (EMIcompass): Findings From an Exploratory Randomized Controlled Trial. Schizophr Bull. 2023.
Wasil AR, Gillespie S, Shingleton R, Wilks CR, Weisz JR. Examining the Reach of Smartphone Apps for Depression and Anxiety. Am J Psychiatry. 2020;177:464–5.
O’Daffer A, Colt SF, Wasil AR, Lau N. Efficacy and Conflicts of Interest in Randomized Controlled Trials Evaluating Headspace and Calm Apps: Systematic Review. JMIR Ment Health. 2022;9:e40924.
Foster AA, Zabel M, Schober M. Youth Crisis: The Current State and Future Directions. Psychiatr Clin North Am. 2024;47:595–611.
McGorry P, Gunasiri H, Mei C, Rice S, Gao CX. The youth mental health crisis: analysis and solutions. Front Psychiatry. 2024;15:1517533.
Weersing VR, Shamseddeen W, Garber J, Hollon SD, Clarke GN, Beardslee WR, et al. Prevention of Depression in At-Risk Adolescents: Predictors and Moderators of Acute Effects. J Am Acad Child Adolesc Psychiatry. 2016;55:219–26.
Young KS, van der Velden AM, Craske MG, Pallesen KJ, Fjorback L, Roepstorff A, et al. The impact of mindfulness-based interventions on brain activity: A systematic review of functional magnetic resonance imaging studies. Neurosci Biobehav Rev. 2018;84:424–33.
Marwood L, Wise T, Perkins AM, Cleare AJ. Meta-analyses of the neural mechanisms and predictors of response to psychotherapy in depression and anxiety. Neurosci Biobehav Rev. 2018;95:61–72.
Schrammen E, Roesmann K, Rosenbaum D, Redlich R, Harenbrock J, Dannlowski U, et al. Functional neural changes associated with psychotherapy in anxiety disorders - A meta-analysis of longitudinal fMRI studies. Neurosci Biobehav Rev. 2022;142:104895.
Li H, Wei D, Browning M, Du X, Zhang Q, Qiu J. Attentional bias modification (ABM) training induces spontaneous brain activity changes in young women with subthreshold depression: a randomized controlled trial. Psychol Med. 2016;46:909–20.
Picó-Pérez M, Fullana MA, Albajes-Eizagirre A, Vega D, Marco-Pallarés J, Vilar A, et al. Neural predictors of cognitive-behavior therapy outcome in anxiety-related disorders: a meta-analysis of task-based fMRI studies. Psychol Med. 2023;53:3387–95.
Goodkind M, Eickhoff SB, Oathes DJ, Jiang Y, Chang A, Jones-Hagata LB, et al. Identification of a common neurobiological substrate for mental illness. JAMA psychiatry. 2015;72:305–15.
McTeague LM, Huemer J, Carreon DM, Jiang Y, Eickhoff SB, Etkin A. Identification of Common Neural Circuit Disruptions in Cognitive Control Across Psychiatric Disorders. Am J Psychiatry. 2017;174:676–85.
Sharma A, Wolf DH, Ciric R, Kable JW, Moore TM, Vandekar SN, et al. Common Dimensional Reward Deficits Across Mood and Psychotic Disorders: A Connectome-Wide Association Study. Am J Psychiatry. 2017;174:657–66.
Insel TR, Gogtay N. National Institute of Mental Health clinical trials: new opportunities, new expectations. JAMA psychiatry. 2014;71:745–6.
Rahrig H, Vago DR, Passarelli MA, Auten A, Lynn NA, Brown KW. Meta-analytic evidence that mindfulness training alters resting state default mode network connectivity. Sci Rep. 2022;12:12260.
Sezer I, Pizzagalli DA, Sacchet MD. Resting-state fMRI functional connectivity and mindfulness in clinical and non-clinical contexts: A review and synthesis. Neurosci Biobehav Rev. 2022;135:104583.
Ochsner KN, Gross JJ. The cognitive control of emotion. Trends Cogn Sci. 2005;9:242–9.
Godsil BP, Kiss JP, Spedding M, Jay TM. The hippocampal-prefrontal pathway: the weak link in psychiatric disorders?. Eur Neuropsychopharmacol. 2013;23:1165–81.
Baltruschat S, Cándido A, Maldonado A, Verdejo-Lucas C, Catena-Verdejo E, Catena A. There Is More to Mindfulness Than Emotion Regulation: A Study on Brain Structural Networks. Front Psychol. 2021;12:659403.
Morawetz C, Basten U. Neural underpinnings of individual differences in emotion regulation: A systematic review. Neurosci Biobehav Rev. 2024;162:105727.
Holt DJ, Sussman R, Johnson D, Vinke L, Berman T, Zimmerman J, et al. Candidate targets for resilience training to reduce transdiagnostic risk for mental illness. Schizophr Bull. In press.
Cuijpers P, van Straten A, Smit F, Mihalopoulos C, Beekman A. Preventing the onset of depressive disorders: a meta-analytic review of psychological interventions. Am J Psychiatry. 2008;165:1272–80.
van Zoonen K, Buntrock C, Ebert DD, Smit F, Reynolds CF, Beekman ATF, et al. Preventing the onset of major depressive disorder: A meta-analytic review of psychological interventions. International J Epidemiol. 2014;43:318–29.
Buntrock C, Ebert DD, Lehr D, Smit F, Riper H, Berking M, et al. Effect of a Web-Based Guided Self-help Intervention for Prevention of Major Depression in Adults With Subthreshold Depression: A Randomized Clinical Trial. Jama. 2016;315:1854–63.
Schuch FB, Vancampfort D, Firth J, Rosenbaum S, Ward PB, Silva ES, et al. Physical Activity and Incident Depression: A Meta-Analysis of Prospective Cohort Studies. Am J Psychiatry. 2018;175:631–48.
Hu MX, Turner D, Generaal E, Bos D, Ikram MK, Ikram MA, et al. Exercise interventions for the prevention of depression: a systematic review of meta-analyses. BMC Public Health. 2020;20:1255.
Guloksuz S, Pries LK, Ten Have M, de Graaf R, van Dorsselaer S, Klingenberg B, et al. Association of preceding psychosis risk states and non-psychotic mental disorders with incidence of clinical psychosis in the general population: a prospective study in the NEMESIS-2 cohort. World psychiatry : Off J World Psychiatr Assoc (WPA). 2020;19:199–205.
Deng W, Addington J, Bearden CE, Cadenhead KS, Cornblatt BA, Mathalon DH, et al. Depression Predicts Global Functional Outcomes in Individuals at Clinical High Risk for Psychosis. Psychiatr Res Clin Pr. 2021;3:163–71.
Koutsouleris N, Dwyer DB, Degenhardt F, Maj C, Urquijo-Castro MF, Sanfelici R, et al. Multimodal Machine Learning Workflows for Prediction of Psychosis in Patients With Clinical High-Risk Syndromes and Recent-Onset Depression. JAMA psychiatry. 2021;78:195–209.
Nestsiarovich A, Reps JM, Matheny ME, DuVall SL, Lynch KE, Beaton M, et al. Predictors of diagnostic transition from major depressive disorder to bipolar disorder: a retrospective observational network study. Translational psychiatry. 2021;11:642.
Addington J, Farris MS, Liu L, Cadenhead KS, Cannon TD, Cornblatt BA, et al. Depression: An actionable outcome for those at clinical high-risk. Schizophr Res. 2021;227:38–43.
Doering S, Lichtenstein P, Gillberg C, Middeldorp CM, Bartels M, Kuja-Halkola R, et al. Anxiety at age 15 predicts psychiatric diagnoses and suicidal ideation in late adolescence and young adulthood: results from two longitudinal studies. BMC Psychiatry. 2019;19:363.
Buckley V, Young AH, Smith P. Child and adolescent anxiety as a risk factor for bipolar disorder: A systematic review of longitudinal studies. Bipolar Disord. 2023;25:278–88.
McGorry PD, Goldstone SD, Parker AG, Rickwood DJ, Hickie IB, Mei C, et al. Cultures for mental health care of young people: an Australian blueprint for reform. Lancet Psychiatry. 2014;1:559–68.
Shah JL, Jones N, van Os J, McGorry PD, Gülöksüz S. Early intervention service systems for youth mental health: integrating pluripotentiality, clinical staging, and transdiagnostic lessons from early psychosis. Lancet Psychiatry. 2022;9:413–22.
Jed. Jed Campus Impact Report. 2024.
Catanzano M, Bennett SD, Tibber MS, Coughtrey AE, Liang H, Heyman I, et al. A Mental Health Drop-In Centre Offering Brief Transdiagnostic Psychological Assessment and Treatment in a Paediatric Hospital Setting: A One-Year Descriptive Study. Int J Environ Res Public Health. 2021;18.
Rickwood D, Paraskakis M, Quin D, Hobbs N, Ryall V, Trethowan J, et al. Australia’s innovation in youth mental health care: The headspace centre model. Early Inter Psychiatry. 2019;13:159–66.
Sim WH, Jorm AF, Yap MBH The Role of Parent Engagement in a Web-Based Preventive Parenting Intervention for Child Mental Health in Predicting Parenting, Parent and Child Outcomes. Int J Environ Res Public Health. 2022;19.
Eugene D, Du X, Kim Y School climate and peer victimization among adolescents: A moderated mediation model of school connectedness and parental involvement. Children and Youth Services Review. 2021;121.
Cox RB, Washburn IJ, Croff JM, Ringwalt CL. Parental School-Involvement and Substance Use? A Novel Family-Based Prevention Strategy for Latino Youth. Family Relat. 2021;70:1178–89.
Hoopes AJ, Brandzel SD, Luce C, Ferguson DM, Shulman L, Chavez B, et al. What Do Adolescents and Their Parents Need From Mental Health Integration in Primary Care? A Qualitative Exploration of Design Insights. J Pediatr Health Care. 2022;36:570–81.
Bolton B, Rooney RM, Hughes A, Hopkins A, Mancini VO. Systematic review and meta-analysis of the prevention of internalizing disorders in early childhood. Front Psychol. 2023;14:1061825.
Funding
Research studies conducted by the authors related to this article have received funding from the National Institute of Mental Health (R0IMH134936, R0IMH127265, R0IMH12542, R0IMH122371 (DJH); K08MH127413 (KWC); K23MH131793 (NRD)), the Massachusetts Department of Mental Health, the Sidney R. Baer Jr Foundation, and the Ruderman Family Foundation.
Author information
Authors and Affiliations
Contributions
NRD and DJH drafted and edited this manuscript; KWC and OB provided critical feedback.
Corresponding author
Ethics declarations
Competing interests
KWC is a paid consultant and member of the Mind Advisory Committee of Sword Health. The remaining authors have no disclosures.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
DeTore, N.R., Balogun, O., Choi, K.W. et al. Transdiagnostic prevention in youth mental health, Part II: interventions. Neuropsychopharmacol. (2025). https://doi.org/10.1038/s41386-025-02234-9
Received:
Revised:
Accepted:
Published:
DOI: https://doi.org/10.1038/s41386-025-02234-9